CDK inhibitor Palbociclib, Purity ≥98%

Synonym: 571190-30-2; PD0332991; PD-0332991; PD 0332991; CDK inhibitor

Product Size

10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Palbociclib is an CDK kinase inhibitor that disrupts cell division processes. It targets Cdk4/cyclin D1, Cdk4/cyclin D3, Cdk6/cyclin D2, and DYRK1A.

Molecular Weight

447.53

Molecular Formula

C₂₄H₂₉N₇O₂

Targets

Cdk4/cyclin D1: 11 nM; Cdk4/cyclin D3: 9 nM; Cdk6/cyclin D2: 16 nM; DYRK1A: 2000 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Palbociclib (PD 0332991) can be used to study the selective inhibition of CDK4/6 in cancer therapy.

Storage

Store at -20ºC.